NO155289C - Analogifremgangsmaate for fremstilling av terapeutisk virksomme 4,5-umettede prostansyrederivater. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk virksomme 4,5-umettede prostansyrederivater.

Info

Publication number
NO155289C
NO155289C NO803592A NO803592A NO155289C NO 155289 C NO155289 C NO 155289C NO 803592 A NO803592 A NO 803592A NO 803592 A NO803592 A NO 803592A NO 155289 C NO155289 C NO 155289C
Authority
NO
Norway
Prior art keywords
saturated
preparation
acid derivatives
analogy procedure
prostanic acid
Prior art date
Application number
NO803592A
Other languages
English (en)
Norwegian (no)
Other versions
NO155289B (no
NO803592L (no
Inventor
Paul Waddell Collins
Raphael Pappo
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of NO803592L publication Critical patent/NO803592L/no
Publication of NO155289B publication Critical patent/NO155289B/no
Publication of NO155289C publication Critical patent/NO155289C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/76Unsaturated compounds containing keto groups
    • C07C59/90Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/76Unsaturated compounds containing keto groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/76Unsaturated compounds containing keto groups
    • C07C59/80Unsaturated compounds containing keto groups containing rings other than six-membered aromatic rings
    • C07C59/82Unsaturated compounds containing keto groups containing rings other than six-membered aromatic rings the keto group being part of a ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/16Radicals substituted by halogen atoms or nitro radicals
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)
NO803592A 1979-11-28 1980-11-27 Analogifremgangsmaate for fremstilling av terapeutisk virksomme 4,5-umettede prostansyrederivater. NO155289C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/098,290 US4271314A (en) 1979-11-28 1979-11-28 4,5-Unsaturated prostanoic acid derivatives

Publications (3)

Publication Number Publication Date
NO803592L NO803592L (no) 1981-05-29
NO155289B NO155289B (no) 1986-12-01
NO155289C true NO155289C (no) 1987-03-11

Family

ID=22268646

Family Applications (1)

Application Number Title Priority Date Filing Date
NO803592A NO155289C (no) 1979-11-28 1980-11-27 Analogifremgangsmaate for fremstilling av terapeutisk virksomme 4,5-umettede prostansyrederivater.

Country Status (23)

Country Link
US (1) US4271314A (xx)
JP (1) JPS5699457A (xx)
AT (1) AT379144B (xx)
AU (1) AU539192B2 (xx)
BE (1) BE886370A (xx)
CA (1) CA1192903A (xx)
CH (1) CH646147A5 (xx)
DE (1) DE3044794A1 (xx)
DK (2) DK504680A (xx)
ES (2) ES497260A0 (xx)
FI (1) FI71552C (xx)
FR (1) FR2473516A1 (xx)
GB (1) GB2065117B (xx)
GR (1) GR72283B (xx)
IE (1) IE50574B1 (xx)
IL (1) IL61575A (xx)
IT (1) IT1207155B (xx)
NL (1) NL191386C (xx)
NO (1) NO155289C (xx)
NZ (1) NZ195666A (xx)
PT (1) PT72129B (xx)
SE (1) SE436873B (xx)
ZA (1) ZA807415B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4529811A (en) * 1981-03-02 1985-07-16 G. D. Searle & Co. Process for isolating organic compounds and lithium salt complexes useful in said process
US4312994A (en) * 1981-03-25 1982-01-26 G. D. Searle & Co. α Chain dienic prostanoic acid derivatives
US4499296A (en) * 1983-11-14 1985-02-12 G. D. Searle & Co. Omega cycloalkyl prostaglandins
US4754059A (en) * 1984-11-07 1988-06-28 G. D. Searle & Co. Omega cycloalkyl prostaglandins
GB8410396D0 (en) * 1984-04-24 1984-05-31 Glaxo Group Ltd Carbocyclic compounds
US5011958A (en) * 1987-06-08 1991-04-30 G. D. Searle & Co. Process for preparing higher order cuprate complexes
US4785124A (en) * 1987-06-08 1988-11-15 G. D. Searle & Co. Process for preparing higher order cuprate complexes
US4777275A (en) * 1987-06-09 1988-10-11 G. D. Searle & Co. Process of preparing higher order cuprate complexes
US5191109A (en) * 1990-02-02 1993-03-02 Sumitomo Chemical Company, Limited Process for preparing optically active cyclopentenones
AU742787B2 (en) 1997-07-09 2002-01-10 Androsolutions, Inc. Improved methods and compositions for treating male erectile dysfunction
US6103765A (en) 1997-07-09 2000-08-15 Androsolutions, Inc. Methods for treating male erectile dysfunction
KR20020067594A (ko) * 2000-01-05 2002-08-22 오노 야꾸힝 고교 가부시키가이샤 5-티아-ω-치환 페닐-프로스타글란딘 E-알콜, 이들의제조 방법 및 이들을 유효 성분으로서 함유하는 약제

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3965143A (en) * 1974-03-26 1976-06-22 G. D. Searle & Co. 16-Oxygenated prostanoic acid derivatives
US4028419A (en) * 1976-01-08 1977-06-07 The Upjoin Company 2-Decarboxy-2-hydroxymethyl-cis-4,5-didehydro-PGE, compounds
GB1595118A (en) * 1977-05-31 1981-08-05 Sumitomo Chemical Co Prostadienoic acids processes for producing them and compositions containing them

Also Published As

Publication number Publication date
DK613487D0 (da) 1987-11-23
JPS5699457A (en) 1981-08-10
IE50574B1 (en) 1986-05-14
ES507577A0 (es) 1982-10-01
DK504680A (da) 1981-05-29
IT8050259A0 (it) 1980-11-27
IE802471L (en) 1981-05-28
JPS6366832B2 (xx) 1988-12-22
FR2473516B1 (xx) 1983-07-29
US4271314A (en) 1981-06-02
IL61575A0 (en) 1980-12-31
DE3044794A1 (de) 1981-08-27
ES8300089A1 (es) 1982-10-01
ATA579280A (de) 1985-04-15
FI803685L (fi) 1981-05-29
CA1192903A (en) 1985-09-03
DK162281C (da) 1992-03-16
FR2473516A1 (fr) 1981-07-17
FI71552C (fi) 1987-01-19
IT1207155B (it) 1989-05-17
PT72129B (en) 1981-09-29
IL61575A (en) 1984-05-31
SE436873B (sv) 1985-01-28
AT379144B (de) 1985-11-25
BE886370A (fr) 1981-05-27
AU539192B2 (en) 1984-09-13
NO155289B (no) 1986-12-01
FI71552B (fi) 1986-10-10
GB2065117A (en) 1981-06-24
NO803592L (no) 1981-05-29
GR72283B (xx) 1983-10-14
AU6476680A (en) 1981-07-02
GB2065117B (en) 1984-09-05
DK613487A (da) 1987-11-23
NL8006473A (nl) 1981-07-01
CH646147A5 (de) 1984-11-15
NL191386B (nl) 1995-02-01
PT72129A (en) 1980-12-01
ZA807415B (en) 1982-07-28
NL191386C (nl) 1995-07-03
SE8008300L (sv) 1981-05-29
NZ195666A (en) 1982-12-21
DE3044794C2 (xx) 1990-02-15
ES8204418A1 (es) 1982-04-01
ES497260A0 (es) 1982-04-01
DK162281B (da) 1991-10-07

Similar Documents

Publication Publication Date Title
NO149102C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive trans-4-fenyl-1,2,3,4-tetrahydro-1-naftalenamin-derivater
NO158099C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.
NO156611C (no) Analogifremgangsmaate for fremstilling av terapeutiske virksomme derivater av hydroksykarbonylfosfonsyre.
NO152215C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4,5-diaryl-2-nitroimidazoler
NO162022C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive cefemderivater.
NO803851L (no) Fremgangsmaate til fremstilling av 4,1`,6`-triklor-4,1`,6`-trideoksy-galaktosukrose
NO156864C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperinderivater.
NO152935C (no) Analogifremgangsmaate for fremstilling av anti-inflammatorisk virksomme tioetiansyrederivater.
NO152129C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive omega-cyan-1, omega-difenyl-azaalkanderivater
NO153569C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive merkaptoacetyl-prolin-derivater.
NO156787C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO153496C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive indolizin-derivater.
NO814424L (no) Fremgangsmaate for fremstilling av terapeutisk virksomme 5,5`-azobis-salisylsyreforbindelser.
NO159654C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive 2-guanidin-4-heteroaryltiazolderivater.
NO162155C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive vinylkarbonoksylsyrederivater.
NO155289C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 4,5-umettede prostansyrederivater.
NO152414C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2,6-dialkoksybenzamider
NO160079C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-derivater.
NO154054C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksypyrimidinderivater.
NO158739C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-piperazinopyrimidinderivater.
NO160511C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklo-butanderivater.
NO160512C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.
NO151660C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolderivater.
NO168478C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive vinylthioacetamido-oxacefalosporinderivater.
NO154795C (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme 1,2,4-oxadiazolin-5-on-derivater.